GREY:ATBPF - Post by User
Comment by
WalkOverTheStrton Jun 01, 2020 10:40pm
249 Views
Post# 31099472
RE:RE:RE:not a slam dunk yet
RE:RE:RE:not a slam dunk yet I'll wait for the full data set to see where the LTEs came in from / those levels were comparable to current NSAIDs (see below).....so I think you are fear mongering esp the ignorant statement they will need to perform another PH2...you have an agenda and good luck with it...
"Acetaminophen use, especially in the post-treatment assessment period, pre-existing liver conditions and concomitant statin use were associated with a majority of the LTE incidents. Accounting for these factors yields clinically significant, temporary LTE incidence rates of 4.5%, 3.2% and 3.3%, respectively, suggesting a liver safety profile for ATB-346 comparable to commonly prescribed NSAIDs and well below that observed with acetaminophen (39% clinically significant LTE incidence rate; National Institutes of Health).